These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

328 related articles for article (PubMed ID: 33330389)

  • 1. A Review of Mesoporous Silica Nanoparticle Delivery Systems in Chemo-Based Combination Cancer Therapies.
    Gao Y; Gao D; Shen J; Wang Q
    Front Chem; 2020; 8():598722. PubMed ID: 33330389
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Application of Mesoporous Silica Nanoparticles in Cancer Therapy and Delivery of Repurposed Anthelmintics for Cancer Therapy.
    Koohi Moftakhari Esfahani M; Alavi SE; Cabot PJ; Islam N; Izake EL
    Pharmaceutics; 2022 Jul; 14(8):. PubMed ID: 36015204
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recent advancements in mesoporous silica nanoparticles towards therapeutic applications for cancer.
    Li T; Shi S; Goel S; Shen X; Xie X; Chen Z; Zhang H; Li S; Qin X; Yang H; Wu C; Liu Y
    Acta Biomater; 2019 Apr; 89():1-13. PubMed ID: 30797106
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Polydopamine-coated mesoporous silica nanoparticles for multi-responsive drug delivery and combined chemo-photothermal therapy.
    Lei W; Sun C; Jiang T; Gao Y; Yang Y; Zhao Q; Wang S
    Mater Sci Eng C Mater Biol Appl; 2019 Dec; 105():110103. PubMed ID: 31546357
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recent advances in mesoporous silica nanoparticle-based targeted drug-delivery systems for cancer therapy.
    Li Y; Deng G; Hu X; Li C; Wang X; Zhu Q; Zheng K; Xiong W; Wu H
    Nanomedicine (Lond); 2022 Aug; 17(18):1253-1279. PubMed ID: 36250937
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bio-Functional Mesoporous Silica Nanoparticles as Nano-Structured Carriers in Cancer Theranostic Review on Recent Advancements.
    Gevariya D; Priya L; Mehta S; Patel V; Bhuva D; Panjwani D; Patel S; Ahlawat P; Dharamsi A; Patel A
    Curr Drug Targets; 2023; 24(12):934-944. PubMed ID: 37592775
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Egg-yolk core-shell mesoporous silica nanoparticles for high doxorubicin loading and delivery to prostate cancer cells.
    Tiburcius S; Krishnan K; Jose L; Patel V; Ghosh A; Sathish CI; Weidenhofer J; Yang JH; Verrills NM; Karakoti A; Vinu A
    Nanoscale; 2022 May; 14(18):6830-6845. PubMed ID: 35441642
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Optimized mesoporous silica nanoparticle-based drug delivery system with removable manganese oxide gatekeeper for controlled delivery of doxorubicin.
    Miao Y; Feng Y; Bai J; Liu Z; Zhao X
    J Colloid Interface Sci; 2021 Jun; 592():227-236. PubMed ID: 33662827
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Functionalized Mesoporous Silica Nanoparticles for Drug-Delivery to Multidrug-Resistant Cancer Cells.
    Igaz N; Bélteky P; Kovács D; Papp C; Rónavári A; Szabó D; Gácser A; Kónya Z; Kiricsi M
    Int J Nanomedicine; 2022; 17():3079-3096. PubMed ID: 35859731
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mesoporous Silica Nanoparticle-Based Drug Delivery Systems for the Treatment of Pancreatic Cancer: A Systematic Literature Overview.
    Slapak EJ; El Mandili M; Bijlsma MF; Spek CA
    Pharmaceutics; 2022 Feb; 14(2):. PubMed ID: 35214121
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mesoporous silica nanoparticles in drug delivery and biomedical applications.
    Wang Y; Zhao Q; Han N; Bai L; Li J; Liu J; Che E; Hu L; Zhang Q; Jiang T; Wang S
    Nanomedicine; 2015 Feb; 11(2):313-27. PubMed ID: 25461284
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gold nanoparticle-gated mesoporous silica as redox-triggered drug delivery for chemo-photothermal synergistic therapy.
    Yang Y; Lin Y; Di D; Zhang X; Wang D; Zhao Q; Wang S
    J Colloid Interface Sci; 2017 Dec; 508():323-331. PubMed ID: 28843922
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Carboxyl-functionalized mesoporous silica nanoparticles for the controlled delivery of poorly water-soluble non-steroidal anti-inflammatory drugs.
    Gou K; Wang Y; Guo X; Wang Y; Bian Y; Zhao H; Guo Y; Pang Y; Xie L; Li S; Li H
    Acta Biomater; 2021 Oct; 134():576-592. PubMed ID: 34280558
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Drug delivery system with dual imaging and dual response control drug release functions for chemo-photodynamic synergistic therapy.
    Wu ZY; Lee ZH; Huang YY; Tsou MH; Lin HM
    J Inorg Biochem; 2022 May; 230():111717. PubMed ID: 35247856
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Silver Mesoporous Silica Nanoparticles: Fabrication to Combination Therapies for Cancer and Infection.
    He X; Chen F; Chang Z; Waqar K; Hu H; Zheng X; Wang Y; Dong WF; Yang C
    Chem Rec; 2022 Apr; 22(4):e202100287. PubMed ID: 35020240
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mesoporous silica nanoparticles: synthesis, classification, drug loading, pharmacokinetics, biocompatibility, and application in drug delivery.
    Li Z; Zhang Y; Feng N
    Expert Opin Drug Deliv; 2019 Mar; 16(3):219-237. PubMed ID: 30686075
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Facile Synthesis of Three Types of Mesoporous Silica Microspheres as Drug Delivery Carriers and their Sustained-Release Properties.
    Zhu Y; Wang B; Chen J; He J; Qiu X
    Curr Drug Deliv; 2023; 20(9):1337-1350. PubMed ID: 35713141
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preparation and Applications of Organo-Silica Hybrid Mesoporous Silica Nanoparticles for the Co-Delivery of Drugs and Nucleic Acids.
    Pontón I; Martí Del Rio A; Gómez Gómez M; Sánchez-García D
    Nanomaterials (Basel); 2020 Dec; 10(12):. PubMed ID: 33317099
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recent Developments in Mesoporous Silica Nanoparticles for Tumor Theranostic Applications.
    Wang X; Zheng M; Raza F; Liu Y; Wei Y; Qiu M; Su J
    Curr Pharm Des; 2022; 28(2):151-164. PubMed ID: 34766889
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Current trends in smart mesoporous silica-based nanovehicles for photoactivated cancer therapy.
    Wang K; Lu J; Li J; Gao Y; Mao Y; Zhao Q; Wang S
    J Control Release; 2021 Nov; 339():445-472. PubMed ID: 34637819
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.